Bcl-2 expression correlates with apoptosis induction but not tumor growth delay in transplantable murine lymphomas treated with different chemotherapy drugs

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue 5, 1999, Pages 367-371

  Story, Michael D ^a   Mirkovic, Nena ^a   Hunter, Nancy ^a   Meyn, Raymond E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adriamycin; Apoptosis; Camptothecin; Cisplatin; Cyclophosphamide; Cytarabine; Etoposide; Tumor growth delay

Indexed keywords

CAMPTOTHECIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GRAFT; CLONOGENIC ASSAY; DOSE RESPONSE; DRUG EFFECT; GENETIC HETEROGENEITY; GROWTH INHIBITION; IONIZING RADIATION; LYMPHOMA; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; LYMPHOMA; MALE; MICE; MICE, INBRED C3H; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0032831848     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050991     Document Type: Article

References (20)

1. 1. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP, Gnyotat D (1993) High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor prognosis to chemotherapy. Blood 18: 3091
2. 2. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nunez G (1993) Expression of apoptosis-suppressing protein Bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 143: 1543
3. 3. Elliott MJ, Stribinskiene L, Lock RB (1998) Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2′-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin. Cancer Chemother Pharmacol 41: 457
4. 4. Gascoyne RD, Adomat SA, Krajewski S, Krajewska M, Horsman DE, Tolcher AW, O'Reilly SE, Hoskins P, Coldman AJ, Reed JC, Connors JM (1997) Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90: 244
5. 5. Joensuu H, Pylkkäen L, Toikkanen S (1994) Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145: 1191
6. 6. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Whitehouse RM, Talbot DC, Gatter KC, Harris AL (1997) Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer. Int J Cancer 74: 565
7. 7. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh JT, Tu SM, Campbell ML (1992) Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52: 6940
8. 8. O'Reilly LA, Harris AW, Tarlinton DM, Corcoran LM, Strasser A (1997) Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. J Immunol 159: 2301
9. 9. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter K, Mason DY (1993) Bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329: 690
10. 10. Pietenpol JA, Papadopoulos N, Markowitz S, Villson JKV, Kinzler KW, Vogelstein B (1994) Paradoxical inhibition of solid tumor cell growth by bcl-2. Cancer Res 54: 3714
11. 11. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10: 1945
12. 12. Reed JC (1995) BCL-2: prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9: 451
13. 13. Sentman CL, Shutter JR, Hockenberry D, Kanagawa K, Korsmeyer SJ (1991) Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879
14. 14. Stephens LC, Ang KK, Schultheiss TE, Milas L, Meyn RE (1991) Apoptosis in irradiated murine tumors. Radiat Res 127: 308
15. 15. Story MD, Meyn RE (1999) Modulation of apoptosis and enhancement of chemosensitivity by decreasing cellular thiols in a mouse B-cell lymphoma cell line that overexpresses bcl-2. Cancer Chemother Pharmacol 44: 362
16. 16. Story MD, Voehringer DW, Malone CG, Hobbs ML, Meyn RE (1994) Radiation-induced apoptosis in sensitive and resistant cells isolated from a mouse lymphoma. Int J Radiat Biol 66: 659
17. 17. Strasser A, Harris AW, Cory S (1991) Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889
18. 18. Viale G, Roncalli M, Grimelius L, Graziani D, Wilander E, Johansson H, Bergholm U, Coggi G (1995) Prognostic value of Bcl-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol 26: 945
19. 19. Waldman T, Lengauer C, Kinzler KW, Vogelstein B (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713
20. 20. Wouters BG, Giaccia AJ, Denko NC, Brown JM (1997) Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. Cancer Res 57: 4703